Talk:CanSino Biologics

This is the talk page for discussing improvements to the CanSino Biologics article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article is rated Stub-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

China Low‑importance

	China portal This article is within the scope of WikiProject China, a collaborative effort to improve the coverage of China related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.ChinaWikipedia:WikiProject ChinaTemplate:WikiProject ChinaChina-related articles
Low	This article has been rated as Low-importance on the project's importance scale.

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

COVID-19 Low‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
Low	This article has been rated as Low-importance on the project's importance scale.

Daily pageviews of this article

A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org

Failed deal with CanSino Biologics delayed made-in-Canada COVID-19 vaccine plans

this is big news in canada it should be added as a ne heading to the page https://www.cbc.ca/news/canada/cansino-deal-canada-nrc-fifth-estate-1.6208241 — Preceding unsigned comment added by 65.39.44.156 (talk) 17:02, 14 October 2021 (UTC)[reply]

Read: China-made mRNA COVID-19 vaccine starts trial production

Channel News Asia, channelnewsasia.com, says CanSino will be making China's first mRNA vaccine, 7 January 2023 Sudzydoogiedawg (talk) 02:25, 8 January 2023 (UTC)[reply]

Talk:CanSino Biologics

Failed deal with CanSino Biologics delayed made-in-Canada COVID-19 vaccine plans

Read: China-made mRNA COVID-19 vaccine starts trial production

Navigation menu

Search